FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 357:1650-1653 October 18, 2007 Number 16 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear Related Article by Mayrand, M.-H. Related Article by Naucler, P. PubMed Citation

In 1943, Papanicolaou and Traut published their famous monograph on vaginal cytology as a screening method for uterine cancer.¹ Since then, the Papanicolaou (Pap) smear has become the most commonly used method to screen for cervical neoplasia, and it is the best screening tool ever introduced for any cancer. The remarkable success achieved in preventing cervical cancer is largely attributable to cytologic screening tests. With the introduction of organized cervical cytologic-screening programs, the incidence of cervical cancer has been dramatically reduced. However, high-quality cytology-based screening programs require highly trained personnel and some specialized equipment. Cytologic screening tests for cervical neoplasia . . . [Full Text of this Article]

Source Information

From the Carole and Ray Neag Comprehensive Cancer Center, University of Connecticut Health Center, Farmington.

Related Letters:

Human Papillomavirus DNA versus Papanicolaou Screening Tests for Cervical Cancer
Lytwyn A., Elit L., Sellors J. W., Lin B. T., Frank A. P., Berkhof J., Meijer C. J., Fields R. P., Franco E. L., Mayrand M.-H., Ratnam S., the Canadian Cervical Cancer Screening Trial Study Group , Runowicz C. D.
Extract | Full Text | PDF  
N Engl J Med 2008; 358:641-644, Feb 7, 2008. Correspondence

This article has been cited by other articles:

• Wong, S. C. C., Au, T. C. C., Chan, S. C. S., Chan, C. M. L., Lam, M. Y. Y., Zee, B. C. Y., Pong, W. M., Chan, A. T. C. (2010). Human Papillomavirus DNA Detection in Menstrual Blood from Patients with Cervical Intraepithelial Neoplasia and Condyloma Acuminatum. J. Clin. Microbiol. 48: 709-713 [Abstract] [Full Text]  
• Lytwyn, A., Elit, L., Sellors, J. W., Lin, B. T., Frank, A. P., Berkhof, J., Meijer, C. J., Fields, R. P., Franco, E. L., Mayrand, M.-H., Ratnam, S., the Canadian Cervical Cancer Screening Trial Study, , Runowicz, C. D. (2008). Human Papillomavirus DNA versus Papanicolaou Screening Tests for Cervical Cancer. NEJM 358: 641-644 [Full Text]  
• Linos, E., Linos, E., Colditz, G. (2007). Screening programme evaluation applied to airport security. BMJ 335: 1290-1292 [Full Text]  
• (2007). HPV vs. Pap Smear for Cervical Abnormalities. JWatch General 2007: 5-5 [Full Text]  
• (2007). Combined Pap Smear and HPV Testing Improves Cervical Cancer Detection. JWatch Infect. Diseases 2007: 2-2 [Full Text]